HB Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$58M Buy
63,028
+3,907
+7% +$3.96M 0.38% 39
2025
Q4
$63.5M Buy
59,121
+2,252
+4% +$2.15M 0.41% 35
2025
Q3
$43.4M Buy
56,869
+4,068
+8% +$3.03M 0.29% 44
2025
Q2
$41.2M Sell
52,801
-2,494
-5% -$1.94M 0.33% 43
2025
Q1
$45.7M Buy
55,295
+11,512
+26% +$9.58M 0.38% 38
2024
Q4
$33.8M Buy
43,783
+1,214
+3% +$1.01M 0.35% 34
2024
Q3
$37.7M Buy
42,569
+1,109
+3% +$997K 0.4% 28
2024
Q2
$37.5M Buy
41,460
+2,745
+7% +$2.2M 0.44% 27
2024
Q1
$30.1M Buy
38,715
+1,101
+3% +$784K 0.38% 31
2023
Q4
$21.9M Buy
37,614
+1,903
+5% +$1.11M 0.32% 35
2023
Q3
$19.2M Sell
35,711
-12,633
-26% -$6.51M 0.31% 36
2023
Q2
$22.7M Buy
48,344
+32,016
+196% +$13.4M 0.36% 31
2023
Q1
$5.61M Sell
16,328
-255
-2% -$86K 0.1% 106
2022
Q4
$6.07M Buy
16,583
+1,732
+12% +$614K 0.11% 97
2022
Q3
$4.8M Sell
14,851
-572
-4% -$181K 0.1% 98
2022
Q2
$5M Buy
15,423
+500
+3% +$150K 0.1% 100
2022
Q1
$4.27M Buy
14,923
+2,547
+21% +$655K 0.08% 121
2021
Q4
$3.42M Buy
+12,376
New +$3.14M 0.07% 113

Other funds holding LLY

HB Wealth Management's LLY Position: Q1 2026 in Review

HB Wealth Management increased its Eli Lilly (LLY) stake by 6.6% in Q1 2026, buying an estimated $3.96M and bringing the position to 63,028 shares worth $58M. The position accounts for 0.38% of the portfolio, ranked #39.

HB Wealth Management first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $63.5M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • HB Wealth Management held 63,028 shares of Eli Lilly worth $58M as of Q1 2026.
  • HB Wealth Management bought 3,907 Eli Lilly shares in Q1 2026, an estimated $3.96M.
  • Eli Lilly made up 0.38% of HB Wealth Management's portfolio in Q1 2026, its #39 holding.
  • HB Wealth Management first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • HB Wealth Management's Eli Lilly position peaked at $63.5M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on HB Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.